The present disclosure generally relates to a system and a method to determine critical process parameters for a continuous viral inactivation reactor and to design and manufacture the same.
Presently, defining the residence time of the viral particles in a plug-flow-reactor (PFR) is difficult to quantify due to fluid dynamics phenomena that occur during flow of a process stream in circular piping where the flow of a process stream in the center of the pipe can be twice as fast as the average flow of the process stream and almost stagnant near the wall of the pipe. Thus, presently the only way to determine the correct PFR parameters for viral inactivation is by experimentation. This trial-and-error approach is inefficient and time-consuming.
In an aspect, a method for designing, selecting, making, and/or manufacturing of an actual plug-flow reactor is described. The method includes introducing a process stream including detectable particles/tracer into an experimental reactor having a known radius of curvature and a known internal diameter, wherein the experimental reactor is in communication with at least one of a first detector and a second detector; detecting a flow rate of the process stream in the experimental reactor by at least one of the first detector and the second detector; detecting fluid-phase parameters of the process stream by at least one of the first detector and the second detector; detecting the detectable particles/tracer exiting the experimental reactor by the second detector; determining, based on the introduced process stream including the detectable particles/tracer, empirical values relating to at least one of experimental reactor parameters and fluid-phase parameters; determining non-empirical values relating to at least one of the experimental reactor parameters and the fluid-phase parameters; and designing, selecting, making, and/or manufacturing the actual reactor based on the determined empirical values and the determined non-empirical values.
In an aspect, a system to determine, select, make, and/or manufacture an actual reactor size is described. The system comprises a processor; and a non-transitory machine-readable storage medium storing machine-readable instructions that are executable by the processor to receive parameters of an experimental reactor that is in communication with at least one of a first detector and a second detector; detect flow rate of a process stream including detectable particles/tracer in the experimental reactor by at least one of the first detector and the second detector; detect fluid-phase parameters of the process stream in the experimental reactor by at least one of the first detector and the second detector; detect the detectable particles/tracer exiting the experimental reactor by the second detector; determine empirical values of at least one of reactor parameters of the experimental reactor and fluid parameters of the process stream; determine non-empirical values of at least one of the reactor parameters of the experimental reactor and the fluid parameters of the process stream; design, select, make, and/or manufacture an actual reactor for an actual process stream having a predetermined volume of fluid, wherein the fluid includes substantially similar parameters as the fluid parameters in the experimental reactor.
In another aspect, a system for designing, selecting, making, and/or manufacturing an actual reactor for continuously inactivating virus during manufacturing of a biological product is described. The system comprises an experimental reactor having a known radius of curvature and a known diameter and designed to receive a process stream; at least one of a first detector and a second detector in communication with the experimental reactor, wherein the at least one of the first detector and the second detector detects fluid-phase parameters of the process stream and wherein the second detector detects detectable particles/tracer exiting the experimental reactor; a processor; and a non-transitory machine-readable storage medium storing machine-readable instructions that are executable by the processor to: determine empirical values corresponding to parameters of at least one of the experimental reactor and fluid of the process stream; determine non-empirical values corresponding to parameters of at least one of the experimental reactor and fluid of the process stream; and based on the determined empirical values and the determined non-empirical values, design, select, make, and/or manufacture the actual reactor for an actual process stream having a predetermined volume of fluid.
In a further aspect, a system for designing, selecting, making, and/or manufacturing an actual reactor for continuously inactivating virus during manufacturing of a biological product is provided. The system comprises an experimental reactor having an inlet, an outlet, and a tubular flow path comprising a set of alternating turns that form a serpentine pattern between the inlet and the outlet, wherein the serpentine pattern includes a predetermined radius of curvature and a predetermined diameter and wherein the experimental reactor is designed to receive a process stream; at least one of a first detector and a second detector in communication with the experimental reactor, wherein the at least one of the first detector and the second detector detects fluid-phase parameters of the process stream and wherein the second detector detects detectable particles/tracer exiting the experimental reactor; a processor; and a non-transitory machine-readable storage medium storing machine-readable instructions that are executable by the processor to: determine empirical values of at least one of the experimental reactor parameters and the fluid parameters of the process stream; determine non-empirical values of at least one of the reactor parameters of the experimental reactor and the fluid parameters of the process stream; and design, select, make, and/or manufacture the actual reactor based on the determined empirical values and the determined non-empirical values, wherein the actual reactor includes a serpentine pattern substantially similar to the serpentine pattern of the experimental reactor, but configured to accommodate an actual process stream having a predetermined volume of fluid.
In yet another aspect, a system for designing, selecting, making, and/or manufacturing an actual reactor for continuously inactivating virus during manufacturing of a biological product is provided. The system comprises an experimental reactor having an inlet, an outlet, and at least one interwoven tubular flow path comprising a plurality of turns that are in different, non-parallel planes; at least one of a first detector and a second detector in communication with the experimental reactor, wherein the at least one of the first detector and the second detector detects fluid-phase parameters of the process stream and wherein the second detector detects detectable particles/tracer exiting the experimental reactor; a processor; and a non-transitory machine-readable storage medium storing machine-readable instructions that are executable by the processor to: determine empirical values of at least one of the experimental reactor parameters and the fluid parameters of the process stream; determine non-empirical values of at least one of the reactor parameters of the experimental reactor and the fluid parameters of the process stream; and design, select, make, and/or manufacture the actual reactor based on the determined empirical values and the determined non-empirical values, wherein the actual reactor includes an interwoven tubular flow path substantially similar to the interwoven tubular flow path of the experimental reactor, but designed and configured to accommodate an actual process stream having a predetermined volume of fluid.
Additional features and advantages of various embodiments will be set forth, in part, in the description that follows, and will, in part, be apparent from the description, or may be learned by the practice of various embodiments. The objectives and other advantages of various embodiments will be realized and attained by means of the elements and combinations particularly pointed out in the description herein.
The present disclosure in its several aspects and embodiments can be more fully understood from the detailed description and the accompanying drawings, wherein:
Throughout this specification and figures like reference numbers identify like elements.
It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only, and are intended to provide an explanation of various embodiments of the present teachings.
In the description below, the phrase “experimental reactor” refers to a reactor that is used for non-commercial purposes, such as low volume runs, mock runs, initial data gathering, etc. Additionally, the phrase “actual reactor” refers to a reactor that is used for any other purposes that the experimental reactor is not used. Such purposes include, for example, commercial purposes. Furthermore, the phrase “hypothetical reactor” refers to an experimental reactor, wherein its data was previously collected, thus, there is no reason to conduct the experiment again. The phrases “first detector” and “second detector” refer to one or more detectors capable of detecting different characteristics of the process stream and its content.
In an example, the process for manufacturing a biological product can include continuous viral inactivation, using a PFR, by continuously adding and homogenizing a viral inactivating agent to a product containing feed stream (process stream). From there, the process stream can be pumped through and/introduced to the PFR and maintained at this viral inactivating condition for a predetermined amount of time. Defining the residence time of the viral particles in a PFR is difficult to quantify due to the flow of the process stream in the center of the pipe being twice as fast as the average flow of the process stream and almost stagnant near the wall of the pipe. To determine an optimum residence time of the viral particles, a new design or manufactured PFR can include a set of alternating turns that form a serpentine pattern between an inlet and an outlet, thus creating a serpentine-like flow path, interwoven path, and/or a Jig-in-a-Box (JIB) design that generates Dean Vortices to promote radial mixing can be utilized, as described in commonly owned and co-pending U.S. patent applications entitled “A Novel Continuous Flow Reactor For Low pH Viral Inactivation” and “Continuous Flow Reactor for Viral Inactivation” the specifications of which are incorporated herein by reference. In this new design or manufactured PFR, the ability to predict when the first viral particle exits the reactor is essential. Generally, three alternative approaches may be used to determine or estimate a minimum residence time experienced by a discrete detectable particle or detectable tracer equivalent to an incubation time for batch viral inactivation (Tmin). One approach assumes ideal uniformity in the flow path (i.e. plug flow) and simply divides the reactor volume by the flow rate. However, this idealistic approach can result in underestimating the required residence time, even with the increasing efficiency of the reactor having a serpentine-like flow path or an interwoven flow path. Another approach is to assume that the center of the flow path remains twice as fast as the average velocity of the process stream. This approach, however, can result in overestimating the required residence time of the process stream resulting from the increased efficiency of the serpentine-like or interwoven reactor. Another approach uses process development to determine an efficiency coefficient by which to modify the idealistic approach to account for non-idealities. However, this approach requires testing of an at-scale JIB and fails to account for potential anomalies in viscosity and flow rates. Thus, the system and method of the present invention use an inventive technological solution to accurately extrapolate JIB performance across path lengths, flowrates, reactor designs, internal diameters, and viscosities.
Being able to predict Tmin allows for the estimation and/or configuration of the desired flow rates and reactor size required to fit a process.
This is especially useful when submitting data to regulatory agencies, such as the Food and Drug Administration (FDA), where compliance with applicable regulations requires data verification. The systems below will allow a user to run a small scale process stream for data verification purposes and then scale the reactor for mass production, without compromise to the process stream or final results of the process stream during scale-up. Given that the viral inactivating conditions can also degrade the target product as a function of residence time, maximum residence time (Tmax) spent in the reactor (i.e., maximum residence time experienced by the last significant amount of target product leaving the reactor) should also be determined. The present invention is the first known approach to account for the target product stability. The first application of the system and method allows the use of Tmin and Tmax to solve for the operational flow rate and the path length of the JIB. The second application takes the opposite approach, in that the operational flow rate and path length are used to predict the Tmin and Tmax. The third application is a way to approximate the internal diameter and path length required for a certain Tmin when scaling the size of the reactor. In each of these applications, the impact of viscosity, Dean Number, and reactor volume on the residence time distribution are to be determined and quantified. In each of these applications, a user can select if the user would like to use a reactor having a substantially same diameter or a reactor with a different diameter (i.e., scaling the reactor). Alternatively or additionally, the system can recommend whether a same size reaction tube reactor should be used in the actual process as in the experimental reactor or if the experimental reactor should be scaled up or down. In this alternative or additional example, when the reactor is being scaled up or down, the system or the user can select that the experimental reactor and the actual reactor have the same aspect ratio, as shown in
Continuous Flow Reactor Having a Tubular Flow Path with a Set of Alternating Turns that Form a Serpentine Pattern
As stated above, the system can design, select, make, and/or manufacture an actual reactor having a reactor tube with a serpentine pattern. The details of the serpentine pattern are described in
In an example, each curve 10 in the tubular flow path 12 can include the same radius, such as a radius of 1 cm. In another example, each curve 10 in the tubular flow path 12 can include a different radius. For example, the first curve 10 can include a radius R1, which can be 1 cm and the second curve 10 can include a radius R2, which can be 1.02 cm. In this example, the angle of the curvature corresponding to the radius R1 can be about 270° and the angle of the curvature corresponding to the radius R2 can be about 278.27°. In another example, the first half of a curve 10 in each tubular flow path 12 can include a first radius R1, which can be 1 cm and the second half of the curve 10 in each tubular flow path 12 can include a second radius R2, which can be 1.02 cm.
Referring to
Referring to
In an example, as shown in
The connector 18 can be connected to each tubular flow path 12 or flange 20 by a clamp 22, as shown in
In an example, the in-line tubular CVI reactor 10 can include a body or footprint of 20×4.9×23 cm and can contain a flow path 12 length of approximately 16.43 m resulting in approximately a 520 ml flow volume. The body of the in-line tubular CVI reactor 10 can include a first side 24 and a second side 26, as shown in
As stated above, the system can design, select, make, and/or manufacture an actual reactor having an interwoven reactor tube. The details of the interwoven reactor tube are described in
Additionally or alternatively, when the continuous flow reactor includes an interwoven tubular flow path, the interwoven tubular flow path can include from about 6 to about 100, such as from about 6.5 to about 93.2 turns per 1 m3.
In another example, not shown in the figures, a path of the continuous flow reactor tube 10Z can include two or more different patterns, which may or may not be repeated. When the continuous flow reactor tube 10Z includes a plurality of interwoven flow paths, each path of the continuous flow reactor tube 10Z can include a substantially similar pattern. Alternatively, or additionally, each path of the continuous flow reactor tube 10Z can include a different pattern. Moreover, each path of the continuous flow reactor tube 10Z can include a similar number of repeated patterns (for example two similarly repeated patterns) or can include more or less than two repeated patterns. For example, the second path can include two similarly repeated patterns or can include three similarly repeated patterns.
Referring to
In an example, the plurality of turns 14Z can follow a three-dimensional path that may include flow direction change at approximately 45° at a turn center. Additionally, each of the plurality of turns 14Z can include an angle of from about 125° to about 180°.
Referring to
In an example, the experimental reactor 100 can be a hypothetical reactor having certain known parameters. Generally, the experimental reactor 100 can be a fixed reactor that includes a constant internal diameter i.d. and radius of curvature Rc (cm) of a reactor tube. The known empirical values and the non-empirical values are task-dependent. That is, depending on what the user would like to accomplish, the values of at least some of the reactor parameters and/or the fluid parameters may be empirical or non-empirical. In an example, the primary variables associated with the empirical and non-empirical values relating to the reactor parameters and/or the fluid parameters can be the Tmin, the Tmax, the internal diameter i.d., the volumetric flow rate Q (mL/min) of the process stream, the path length L (cm) of the flow path, the radius of curvature Rc (cm) of the reactor tube, the density (ρ) of the fluid in the process stream, and the dynamic viscosity μ (mPa·s) of the fluid in the process stream, and the variance σ2time (min2).
In an example, the empirical values can be values that correspond to experimental reactor parameters and/or fluid-phase parameters that are linear to an experimental set of data. In an example, as shown in
Referring to
As shown in
The limiting factors for designing, selecting, making, manufacturing, and/or determining the actual reactor 400 can be product stability, required viral incubation, process parameters, and/or no operational or kinetics consideration.
When the limiting factor is the product stability, a target protein that is highly sensitive to viral inactivation chemical is provided. In this example, the system 1000 can be made to determine an acceptable reactor length and flow rate based on the minimum residence time required for viral inactivation kinetics and maximum residence time limitation for product stability. When the limiting factor is the process parameters, the downstream process is limited by the volumetric flow rate Q and the path length L. In this example, the system 1000 can be made to determine process stream minimal residence time required for viral inactivation and maximum residence time for product stability. When there are no operational or kinetics considerations, the target protein may not include stability considerations. In this example, the system can be made to determine the proper Q and L for a resulting Tmin.
Limiting Factor Product Stability—System and Method to Use Tmin and Tmax to Determine the Operational Flow Rate and the Path Length of an Actual Reactor
In an example, a user, using the system 1000, can develop or create an actual reactor based on a desired pre-determined Tmin and Tmax. For example, the user requires that the Tmin be 60 minutes and that the Tmax be 75 minutes. Additionally, the user can input the desired internal diameter of the reaction tube of the experimental reactor 100 and the radius of curvature of the experimental reactor 100. In this particular example, the experimental reactor 100 and the actual reactor 400 can include identical internal diameter i.d. and radius of curvature Rc. Moreover, referring to
Referring to
Additionally, referring to
The empirical values can then be determined using pulse injection of the process stream into the experimental reactor 100, as described above. For example, referring to
T
Ave
=T
min+(n*σmax), wherein n can be 5; (1)
T
Ave
=T
max−(m*σmax), wherein m can be 3 (2)
ΔT=8σmax (3)
15=8σmax (4)
σtime=1.875 min, σ2time=3.52 min2, TAve−69.375 min
Given the determined variance σ2time, TAve, and standard deviation σtime, the comparator 50, utilizing the data from the first and second detectors 30 and 40, respectively, can derive at the empirical values to determine the theoretical plate (HETP) in cm2 and/or Dean Number De, as discussed above. For example, HETP can be defined as follows:
HETP=(aDe3+bDe2+cDe+d), (5)
where De is the Dean Number, a, b, c, and d are based on empirical data fits only valid for Dean Number≥100.
By applying a panel of Dean Number (De)≥100, each De fixes a flow rate Q and returns an HETP, as shown below.
In an example, as shown in
T
Ave
=T
min+(n*σtime), wherein n can be 5 (10)
T
Ave
=T
max−(m*σtime), wherein m can be 3 (11)
For a constant TAve, fixing a Q value fixes a corresponding LTAve value. Each Q value and LTAve value combination returns a resulting σ2time value as shown below.
Solving σ2time results in a minimum reactor volume that is constrained by TAve=Tmin+(5*σmax) and TAve=Tmax−(3*σmax).
Given that in this example, the experimental reactor and the actual reactor are the same, based on the selected flow rate Q and the corresponding reactor tube path length, a series of reactors can be connected to one another to achieve the corresponding reactor tube path length.
Limiting Factor is Process Parameters—System and Method to Use Reactor Volume RV and Flow Rate Q to Dictate the Tmin and Tmax
In an example, a user, using the system 1000, can determine the Tmin and the Tmax of a reactor having known reactor parameters and fluid-phase parameters. For example, as shown in
Referring to
Additionally, at 252, the density (ρ) of the fluid in the process stream can be entered into the system 1000. At 254, the dynamic viscosity (μ) can be entered into the system 1000. Thus, in this particular example, the inputted known values corresponding to the fluid-phase parameters at 250B can be density ρ and the dynamic viscosity μ.
Based on the known process stream flow rate Q (e.g., 50 mL/min), the known reactor volume RV (e.g., 3120 mL), the known internal diameter of a reaction tube i.d., and the known radius of curvature Rc, the processor 1001 of the system 1000 can predict and determine Tmin and Tmax.
To predict and/or determine the Tmin and Tmax, the known values can be entered into the comparator 50. The comparator 50, at 260B, using the experimental reactor as described above, can utilize the process stream flow rate Q and the reactor volume RV to predict and/or determine the average residence time (TAve) as shown in the equations below.
Once the comparator 50 derives the TAve value, the comparator 50 can then utilize the TAve, Q, De, Rv, and L to predict and/or determine the variance σ2time using the experimental reactor 100 and the equations below.
HETP=(aDe3+bDe2+cDe+d), where De is the Dean Number, a, b, c, and d are based on empirical data fits only valid for Dean Number≥100.
For a Q of 50 mL/min and a De of 118.94, the HETP can equal to 7.464 cm. Based on this derived HETP value, the variance σ2time can be predicted or determined by the comparator 50 using the equations below.
The above empirical values and known values can then be forwarded to the system at 200. The processor 1001 having derived at variance σ2time, can utilize this variance σ2time, the standard deviation σtime, reactor tube length L, radius of curvature Rc, Dean Number De, flow rate Q, and TAve, to estimate and/or determine the Tmin and Tmax for the actual reactor as shown in the equations below.
T
Ave
=T
min+(n*σmax), wherein n can be 5 (20)
T
Ave
=T
max−(m*σmax), wherein m can be 3 (21)
Tmin=53.81 min (22)
max=67.55 min (23)
In an example, as shown in
In an example, a user, using the system 1000, can develop or create an actual reactor based on a desired pre-determined Tmin (60 min), process stream flow rate Q (50 mL/min), internal diameter i.d. of the reaction tube (0.635 cm), the radius of curvature Rc, density ρ, and the dynamic viscosity μ. For example, as shown in
Referring to
Additionally, at 252, the density (ρ) of the fluid in the process stream can be entered into the system 1000. At 254, the dynamic viscosity (μ) can be entered into the system 1000. Thus, in this particular example, the inputted known values corresponding to the fluid-phase parameters at 250C can be density (ρ) and the dynamic viscosity (μ).
Based on the known Tmin, process stream flow rate Q (e.g., 50 mL/min), the known internal diameter of a reaction tube i.d., and the known radius of curvature Rc, the processor 1001 of the system 1000 can predict and determine the reaction tube flow path length L of an actual reactor 400.
To predict and/or determine the reaction tube flow path length L of an actual reactor 400, the known values can be entered into the comparator 50. The comparator 50, at 260C, using the experimental reactor as described above, can utilize the Tmin, the process stream flow rate Q and the Dean Number De, to predict and/or determine the TAve and variance σ2time, as shown in the equations below.
Wherein a, b, c, and d are based on empirical data fits only valid for Dean numbers≥100
wherein n can be 5
By re-arranging the equation
Referring to
Solving the equation above, L will equal to 108.99 m or a reactor volume of 3.46 L. Referring to
In all of the above examples, the internal diameter i.d. and the radius of curvature of the experimental reactor 100 and the actual reactor 400 remain the same. However, in an example, as described below, the system can also design, select, make, manufacture, and recommend a reactor that includes an internal diameter i.d. of the reaction tube that differs from the internal diameter i.d. of the experimental reactor. This is especially useful when submitting data to regulatory agencies, such as the FDA, where applicable regulations require data to demonstrate compliance. The system below will allow a user to run a small scale process stream for data purposes and then scale it up for mass production, without having any significant changes to the process stream or final results of the process stream during scaled-up production.
In an example, a user, using the system 1000, can develop or create an actual reactor 400 based on a desired pre-determined Tmin (60 min), process stream flow rate QExit (100 mL/min), density ρ, and the dynamic viscosity μ, and a known aspect ratio. For example, as shown in
Referring to
Additionally, at 252, the density (ρ) of the fluid in the process stream can be entered into the system 1000. At 254, the dynamic viscosity μ can be entered into the system 1000. Thus, in this particular example, the inputted known values corresponding to the fluid-phase parameters at 250D can be density ρ and the dynamic viscosity μ.
To predict and/or determine the reaction tube flow path length L and the internal diameter i.d. of an actual reactor 400, the known values can be entered into the comparator 50. The comparator 50, at 260D, using the experimental reactor 100 as described above, can utilize the Tmin and the process stream flow rate Q to predict and/or determine the TAve and variance σ2time, as shown in the equations below.
HETP=f(v)=(av3+bv2+cv+d), wherein a, b, c, and d are based on empirical data fits for all Dean numbers (32)
T
Ave
=Tmin+(n*σtime), wherein n can be 5 (33)
T
Ave
=T
max−(m*94time), wherein m can be 3 (34)
Q=v*CA (36)
By re-arranging the equations
Referring to
L=1/2*(25f(v)2±5*√{square root over (25f(v)4f(v)2Tmin*v)}+2*Tmin*v) (40)
In an example, scaling of the reactor can include at least one of (i) scaling dimensions of the experimental reactor to the actual reactor having the same aspect ratio as the experimental reactor, but a different internal diameter; (ii) scaling the dimensions of the experimental reactor to the actual reactor having the same aspect ratio and a same internal diameter as the experimental reactor; (iii) scaling the dimensions of the experimental reactor to the actual reactor having a different aspect ratio than the experimental reactor and a different diameter than the experimental reactor; (iv) scaling the dimensions of the experimental reactor to the actual reactor having a different aspect ratio as the experimental reactor, but a same diameter as the experimental reactor.
Once L has been determined, the system 1000, based on the derived values of reactor length L, standard deviation σtime, and the average linear flow velocity (cm/min), can determine the internal using the equations below:
For this particular example, in order to design, select, make, and/or manufacture the actual reactor having a fixed aspect ratio a plot can be derived between the HETP and the linear flow velocity. For example,
As shown at 312 and 320 of
Referring to
Additionally, at 252, the density (ρ) of the fluid in the process stream can be entered into the system 1000. At 254, the dynamic viscosity μ can be entered into the system 1000. Thus, in this particular example, the inputted known values corresponding to the fluid-phase parameters at 250D can be density ρ and the dynamic viscosity μ.
To predict and/or determine the reaction tube flow path length L and the internal diameter i.d. of an actual reactor 400, the known values can be entered into the comparator 50. The comparator 50, at 260D, using the experimental reactor 100 as described above, can utilize the Tmin, Tmax, and the process stream flow rate Q to predict and/or determine the TAve and variance σ2time, as shown in the equations below.
T
Ave
=T
min+(n*σmax), wherein n can be 5 (45)
T
Ave
=T
max−(m(*σmax)), wherein m can be 3 (46)
ΔT=8σmax (47)
15=8σmax
σtime=1.875 min; σ2time=3.52 min2; TAve=69.375 min
Referring to
a, b, c, and d are based on empirical data fits for all Dean numbers
Fixing an i.d. returns a path length term as shown in
Residence Time Distribution Generation.
The JIB was designed from previous development projects at Boehringer Ingelheim and was 3D printed utilizing SLA Technology by 3D Systems (Rock Hill, S.C.). The riboflavin and dextrose used in creating the mobile phases and pulse tracer were purchased through Thermo Fisher Scientific (Suwanee, Ga.). The viscosities of the solutions were determined by a microVlSC S Viscometer utilizing an A05 Chip (San Ramon, Calif.). The densities of the solutions were determined by a Mettler-Toledo Densito Densometer (Columbus, Ohio).
The mid-scale 3D printed JIB was tested using an Akta Avant 150, while the large-scale JIB was tested using an Akta Pilot 600 by GE Healthcare (Uppsala, Sweden). The JIB was first flushed with 1 reactor volume of the mobile phase. Next, a fixed volume of riboflavin dissolved in the mobile phase was pulse injected and chased out with the mobile phase. This produced the Residence Time Distribution (RTD) profiles upon exiting the reactor detected and quantified by UV-Vis absorbance at riboflavin's absorbance maximums (i.e. 267, 372, and 445 nm). The RTD peaks were then analyzed by fitting a Gaussian distribution. From this fit, the variance of the peak, σ2time which is a measurement of the spread of the RTD, was determined. This method was tested over a series of flow rates and viscosities which were altered by varying concentrations of dextrose. The σ2time values were converted into HETP. An HETP vs. Dean number graph was created and a 3rd order polynomial was fit. Then the following series of equations were utilized:
1. Start governing Equations
c) TAve=Tmin+(5*σtime)
2. Re-arrange Equations
3. Solve for L:
4. Fill Variables
The tables below indicate the Tmin at 15 min, 30 min, and 60 min for mid-scale and large-scale reactors.
Evaluating the Effect of Flow Mechanics on Critical Process Parameters in a Continuous Viral Inactivation Reactor
The JIB was designed from previous development projects and was 3D-printed utilizing SLA Technology by 3D Systems (Rock Hill, S.C.). The riboflavin and dextrose used in creating the mobile phases and pulse tracer were purchased through Thermo Fisher Scientific (Suwanee, Ga.). The viscosities of the solutions were determined by a microVlSC S Viscometer utilizing an A05 Chip (San Ramon, Calif.). The densities of the solutions were determined by a Mettler-Toledo Densito Densometer (Columbus, Ohio).
The small scale and mid-scale 3D-printed JIB were tested using an Akta Avant 150, while the large-scale JIB was tested using an Akta Pilot 600 by GE Healthcare (Uppsala, Sweden). The JIB was first flushed with 1 reactor volume of the mobile phase. Next, a fixed volume of riboflavin dissolved in the mobile phase was pulse injected and evacuated with the mobile phase. This produced the RTD profiles upon exiting the reactor detected and quantified by UV-Vis absorbance at riboflavin's absorbance maximums (i.e. 267, 372, and 445 nm). The internal diameters, flow rates, mobile phases, and a number of JIB s connected in series tested in this study are outlined in Table 1 below.
The peaks were then analyzed by fitting a Gaussian distribution. From this fit, the variance of the peak, (σtime2), which is a measurement of the spread of the RTD, was determined. To better understand the influence of the quantitative value of the variance, Equation 1 was calculated, where Q is the volumetric flow rate. Additionally, the dataset was converted using Equations 2 and 3 where HETP is height equivalent to a theoretical plate, TAve is the mean residence time, RV is reactor volume, and L is the length of the flow path of the JIB.
As seen in
Comparing the path length, the peaks widen with the longer path length. This is a well-characterized observation that is a reproducible phenomenon for PFR's. When the data points from
To understand the driving force for this shift (i.e. the two inflection points), further exploration into previously published work on Dean Vortices was undertaken. Flow patterns were visualized using suspensions in water when between two rotating drums (i.e. Taylor-Couette flow). As the flow increased in velocity in the flow cell, Aider made observations at specific Dean number's at which the flow patterns shifted from laminar to chaotic. A similar experiment was conducted in the JIB using suspended mica in water and found the same laminar to a chaotic flow transition. These specific Dean numbers and corresponding observations outlined in Aider et al. are co-plotted on
The two inflection points and the faster flow rate asymptote correspond to the visually observable manifestations of the flow transitioning from the onset of unstable flow, undulated waves, and full turbulence respectively. Given that for flow in a circular straight pipe, the onset of turbulence is typically observed at a Reynolds number of ˜2000. The JIB was able to simulate turbulent flow behavior at a Reynolds number of ˜174. Due to this large discrepancy, the term “weak turbulence” was used.
In order to prove the validity of the shift of 2 asymptotes and 2 inflection points behavior found in the section above was controlled by the Deans number, the mobile phase's viscosity was increased with three concentrations of dextrose.
To account for this apparent shift in the inflection points and asymptote, the x-axis was normalized by converting the flow rate to Dean Number described in Equation 4 and shown in
To inform the operation of the JIB, two prediction model approaches can be generated. The first uses a lumped data pool approach utilizing all of the experimental data from the various dextrose mobile phase experiments and normalizing the data to HETP and Dean Number (
HETP=aDe3+bDe2+cDe+d (5)
The second approach is applicable if a criterion of the JIB unit operation is to maintain a Dean Number of >100. When this condition is true, an exclusion criterion of only allowing data points collected at the De>100 set point are implemented into the model (
This model has two main applications to be used when determining the design and conditions of the JIB based CVI unit operation:
Starting with an understanding of the minimum residence time required for required viral inactivation and the maximum time the target molecule can be in the acidic condition before impacting product quality, Equations 6 and 7 can be applied to help determine the flow rate and path length required to meet those specifications.
Table 2A illustrated below outlines the quantitative aspect of the choice for the “n” and “m” value for σtime.
The exiting pulse injection is thought of as a Gaussian peak, and therefore its spread is thought of in terms of σ. For example, n=5 (i.e. Tmin(5σ)) is understood to represent that 0.00003% of the product exited the reactor in-between Tmin(2v) and Tmin(5σ). This difference between Tmin(2v) and Tmin(5σ) can be visualized in
In a similar fashion, Table 2B and
This decision would be reliant on the product stability data or accepted yield loss in the presence of the acidic or any other viral inactivating condition. If we combine Equations 6 and 7 we get Equation 9.
T
max
−T
min
=ΔT=(n+m)*σtime (9)
With a defined Tmin and Tmax, a TAve and σtime can be calculated. Using Equations 2, 3, and 5, multiple path lengths and flow rate combinations (i.e. starting with flow rates that yield a De>100) can be found to meet the specifications resulting in
To visualize this ideology and phenomenon, and given a process where the Tmin(5σ) and Tmax(3σ) are strictly defined at >60 min and <79 min respectively,
When the CVI is implemented into real-world operation in a GMP setting, variable flow rates and viscosity are inevitable. With the work conducted in this experimental series, this variability can be addressed by understanding process operational extremes and corresponding worst-case conditions and predict how they propagate into the process outputs. Based on these isocratic viscosity experiments, it appears that the worst-case for viral incubation time is a high viscosity solution. Given that a chromatography elution peak's viscosity experiences one peak maximum, this should, therefore, be considered the worst-case. All other portions of the peak (i.e., the front and tail) will have lower viscosities relative to peak max, a larger Dean number, and therefore better mixing.
To validate this claim, a mock protein peak was generated using dextrose to increase viscosity and NaCl to generate a conductivity trace. In the theoretical case of a protein A column, where the mAb will elute from the column in a Gaussian-like shape with some tailing. This general peak shape was generated used the gradient function of the Akta Avant 150, where the A1 line contained DI Water, A2 contained Riboflavin dissolved in water, and B1 Contained 200 g/L dextrose with approximately 150 mM NaCl. To evaluate the different viscosity gradient locations, four pulse injection locations were chosen with the first occurring before the addition of dextrose (0 g/L dextrose), the 2 peak mid-heights (50 g/L dextrose) and the peak max (100 g/L dextrose).
The phenomena of peak spreading as a function of viscosity occurred in the dynamic composition setting.
Mobile Phases and Flow Chamber:
The JIB was designed from previous development projects, which is described in the pending U.S. Pat. Ser. No. 62/742,534 (incorporated in its entirety by reference herein), and was 3D printed utilizing SLA Technology by 3D Systems (Rock Hill, S.C.). The riboflavin, Tris Buffer Saline (TSB), and dextrose used in creating the mobile phases were purchased through Thermo Fisher Scientific (Suwanee, Ga.). The viscosities of the solutions were determined by a microVlSC S Viscometer utilizing an A05 Chip (San Ramon, Calif.). The densities of the solutions were determined by a calibrated pipette and a scale.
Bacteriophage Selection:
ΦX174 and the corresponding host bacteria E. Coli C were purchased from ATCC (ATCC Catalog #: 13706-B1 and 13706 respectively). The concentration of ΦX174 was quantified by utilizing standard plaque-forming assays, which entailed co-plating the fluid in question and the host bacteria E. Coli C with plating agar (i.e., Tryptic Soy Broth with 0.7% agarose) onto Tryptic Soy Agar plates. The bacteriophage ΦX174 was chosen as the appropriate tracer for this experiment due to some of its innate characteristics. ΦX174 is a relatively resilient bacteriophage where chances of loss in infectivity while suspended in an appropriate mobile phase conditions are low, but can also be easily sanitized with 0.1 M NaOH and a reasonable contact time. The surface characteristics of this bacteriophage are relatively inert compared to other viruses. Previous experience with this bacteriophage had shown significantly less surface adsorption relative to other viral models to both positively charged, hydrophobic, and multi-modal chromatography resins. Therefore, the probability of the virus non-specifically adsorbing in a slightly basic solution with a low ionic strength (i.e., pH 7.5 with 150 mM NaCl) to the 3D printed plastics was low. The plaque morphology of ΦX174 was also advantageous. ΦX174's plaque-forming units (pfu) create very large, bullseye type plaques that are easy to identify.
Preliminary Work
To determine the efficacy of the experimental protocol, a few preliminary experiments were conducted. First, pulse injections of ΦX174 were introduced into the JIB at the highest Dean number (i.e., high flow rate and low viscosity), which corresponds to the most chaotic flow stream due to Dean vortices. The discharge of the JIB was then collected and titered which was able to determine the mass balance of the injection. The result showed that recovered bacteriophage titer was within the typical error associated with a titering assay (i.e., (+/−) 0.5 logs). Sampling the dead volume remaining in the outlet valve, ˜300 pfu/mL persisted. A sanitization program was then created to thoroughly sanitize the injection valve, JIB, and outlet valve with 0.1 M NaOH with a contact time of ≥15 min. After the sanitization cycle, no infectious particle remained in the outlet lines.
Determining Minimum Residence Time (ΦX174):
A 0.32 and 0.64 cm i.d. 3D printed JIB's were tested using an Akta Explorer 100 by GE Healthcare (Uppsala, Sweden). To prepare for the experiment, a 30 mL aliquot of the mobile phase was taken and set aside for spiking. The aliquot was then spiked at 0.06% (v/v) targeting a mobile phase concentration of 106.5 pfu/mL. The spike was purposely spiked at a considerably low level to ensure the fluid properties of the experimental injection were not changed by the ΦX174 spike. Using a syringe, 25 mL of spiked sample was then loaded into a 50 mL capacity Superloop by GE Healthcare (Uppsala, Sweden) while the remaining sample was held on the bench as a holding sample to determine if significant ΦX174 death occurred as a function of mobile phase condition independent of flowing through the JIB. ΦX174 never experienced an off-target mobile phase concentration within the typical error of a titering assay (i.e., (+/−) 0.5 logs). Finally, the empty fraction collection containers were then weighted to determine the tare weight.
To start the experiment, the Akta began pushing mobile phase through the injection valve, in the “Inject” position, into the Superloop to introduce the ΦX174 spiked buffer into the JIB for 3% of the total reactor volume, with the discharge of the flow directed into a large volume container. The injection valve then switched to “Load” position to stop flow of mobile phase through the Superloop and redirected to go directly to the JIB to flush out the injection with the discharge remaining in the same large volume container. After a predetermined amount of time, the outlet valve switched to direct flow from the large volume container to a small volume container. The outlet valve subsequently switched two more times creating two more fractions. The time and volume of the three small and one large fractions were determined by Tmin 3, 4, and 5σ using the modified peak analysis. The outlet flow path for the three small volume fractions were 1 mm capillary PEEK tubing by GE Healthcare (Uppsala, Sweden). When the experiment was completed, the three small and one large container were then weighed. To sample for virus, the dead volume of the capillary tube was then drained in sterile tubes for a sample volume of ˜100 uL. The sample left behind in the capillary tube would have been the last drop of that fraction and can be thought of as an instantaneous grab sample. The entire volume of this grab sample was then titered without dilution; therefore, the issue of “probability of detection of viruses at low concentrations” outlined in ICH Q5A does not apply.
After all post Akta experiment activities were completed, the remaining spiked mobile phase was expelled from Superloop, and the Superloop was taken offline. The injection loop position was then replaced with PEEK capillary tubing and the sanitization step outlined above was completed, and then subsequently quenched with TSB.
Results:
Through preliminary results with the bacteriophage, it was found that the calculation model discussed above provided a very conservative estimate of the minimal residence time (Tmin). To account for this, the raw peaks were modified.
Determining Parameters to Scale a Reactor 5×
In an example, a user, using the reactor in
A best-fit line was applied to the dataset shown in
HETP=f(De)=(aDe3+bDe2+cDe+d), (3)
wherein a, b, c, and d are based on empirical data fits for all Dean numbers. Equation 1 and 3 were then combined and rearranged to create Equation 4, below.
It is required that 99.99997% of the product remain within the reactor for ≥60 minutes (i.e., Tmin), which makes n=5 (in Equation 5, below). Additionally, it is required that 99.865% of the product exit the reactor for ≤90 minutes (i.e. Tmax), which makes m=3 (in Equation 6, below). The maximum kinematic viscosity allowable within the reactor was 1.5*10−6 m2/s. Based off this viscosity and the reactor dimensions mentioned previously, to satisfy the requirement of Dean number≥100, the flow rate within the reactor must be ≥65 mL/min and due to arbitrary process constraints, the flow rate must be ≤95 mL/min
T
Ave
=T
min+(n*σmax), wherein n can be 5 and Tmin can be 60 min (5)
T
Ave
=T
max−(m*(σmax)), wherein m can be 3 and Tmax can be 90 min (6)
From the above constraints, a locus of solutions can be generated to satisfy the constraints. As seen in the table below, four flow rates were solved. The target flow rate, reactor design (i.e., i.d. of the flow path and the radius of curvature), and maximum kinematic viscosity calculate worst-case Dean number. The outputted Dean number was then entered into Equation 3 and that value was inputted into Equation 4. Through a guess and check method, different reactor volumes were cast through a stepwise cascade of equations. A proposed reactor volume was then divided by flow rate to calculate average residence time (see Equation 7, below) and divided by the cross-sectional area of the internal diameter of the flow path to obtain the path length. The path length and average residence time were also inputted into Equation 4 to get a σtime value. Equations 5 and 6 were then used to find the Tmin and Tmax.
Table 1 displays the maximum and minimum reactor volume solutions for each flow rate as a function of a Tmin of 60 min or a Tmax of 90 min. These reactor specifications are displayed in
Additionally, the reactor design specifications in terms of internal diameter, a radius of curvature, flow rate, and path length were determined to satisfy a large scale operation. In this example, the user required the dimensions to operate at 5× the process volumetric flow rate (i.e. 350 mL/min) and also desired to keep the ratio between the internal diameter and radius of curvature to be constant. The dataset shown in
From the foregoing description, those skilled in the art can appreciate that the present teachings can be implemented in a variety of forms. Therefore, while these teachings have been described in connection with particular embodiments and examples thereof, the true scope of the present teachings should not be so limited. Various changes and modifications may be made without departing from the scope of the teachings herein.
The scope of this disclosure is to be broadly construed. It is intended that this disclosure disclose equivalents, means, systems, and methods to achieve the devices, activities and mechanical actions disclosed herein. For each device, article, method, mean, mechanical element or mechanism disclosed, it is intended that this disclosure also encompass in its disclosure and teaches equivalents, means, systems, and methods for practicing the many aspects, mechanisms and devices disclosed herein. Additionally, this disclosure regards a coating and its many aspects, features, and elements. Such a device can be dynamic in its use and operation, this disclosure is intended to encompass the equivalents, means, systems, and methods of the use of the device and/or article of manufacture and its many aspects consistent with the description and spirit of the operations and functions disclosed herein. The claims of this application are likewise to be broadly construed.
The description of the inventions herein in their many embodiments is merely exemplary in nature and, thus, variations that do not depart from the gist of the invention are intended to be within the scope of the invention. Such variations are not to be regarded as a departure from the spirit and scope of the invention.
This application claims the benefit of U.S. Provisional Application No. 62/742,506, filed on Oct. 8, 2018, the content of which is expressly incorporated herein by reference thereto.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2019/054216 | 10/2/2019 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
62742506 | Oct 2018 | US |